콘텐츠로 바로가기
Why do newborns need genomic-based NBS like 3B-NEO?
- Most rare genetic disorders appear healthy at birth externally, yet internally, irreversible damage has already begun — a diagnostic latency period. By using genomic analysis to screen for hundreds of Actionable (medically treatable) conditions that conventional biochemical screening (MS/MS) cannot detect, 3B-NEO secures the therapeutic window before symptoms appear, enabling timely intervention.
- This goes beyond the early detection of disease, as timely interventions—such as dietary management, medication, or gene therapy—can prevent physical and intellectual disabilities and fundamentally improve the patient’s lifelong prognosis.
Post Views: 0
답글 남기기
댓글을 달기 위해서는 로그인해야합니다.